Ledger.Open graph →
SEC Form D · filed June 20, 2018

ReSet Therapeutics, Inc

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN JOSE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Glenn B. Batchelder · San Jose, CADirectorFrederick B. Craves · San Jose, CADirectorSteve B. Kay · San Jose, CADirectorShuichi B. Kurosaki · San Jose, CAExecBlair B. Jackson · San Jose, CADirectorSteve B. Kay · San Jose, CADirectorBlair B. Jackson · San Jose, CADirectorGlenn B. Batchelder · San Jose, CADirectorFrederick B. Craves · San Jose, CADirectorSteve B. Kay · San Jose, CADirectorShuichi B. Kurosaki · San Jose, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗